Collaborations

Key collaborations

Within the University of Basel, ECPM is embedded in the Department of Public Health (DPH) of the Medical Faculty and also has links with the Department of Clinical Research. The DPH regards a strong infrastructure for comparative effectiveness and health economic research as one requirement to position Basel as a primary player in health systems research with its high economic relevance.

Many of ECPM's research activities occur in cooperation with the following institutes of the University of Basel:

 

 

Many of ECPM's research activities occur in cooperation with the following entities of the University of Basel:

ECPM and the named institutes have identified the complementary strengths of each institution and a high potential for synergies and future collaboration. They have expertise in a number of closely related areas, implying large potential for economies of scale and scope. They have therefore joined forces to establish a network of excellence (S-CORE: Swiss Centre for Comparative Effectiveness and Health Economic Research). In early 2017, S-CORE has achieved formal recognition as a Research Network of the University of Basel.

Outside the University of Basel, we cooperate closely with the Epidemiology, Biostatistics and Prevention Institute of the University of Zürich and with the Department of General Internal Medicine, Inselspital, University of Bern  and with the Clinical Trials Unit  of the University of Bern. Since 2007, the Swiss Group for Clinical Cancer Research  (SAKK) and ECPM carry the SAKK Network Outcomes Research, with extensive activities in the areas of cancer-related outcomes research and health economics. Health Technology Assessment activities are performed within the framework of the Swiss Medical Board.

 

Outside the University of Basel, we cooperate closely with the Epidemiology, Biostatistics and Prevention Institute  of the University of Zürich and with the Department of General Internal Medicine, Inselspital, University of Bern and with the Clinical Trials Unit  of the University of Bern. Since 2007, the Swiss Group for Clinical Cancer Research (SAKK) and ECPM carry the SAKK Network Outcomes Research, with extensive activities in the areas of cancer-related outcomes research and health economics. Health Technology Assessment activities are performed within the framework of the Swiss Medical Board.

International cooperation occurs within project consortia performing European Union-funded projects, and within the Impact of Neutropenia in Chemotherapy-European Study Group .

 Project partners

Partners at the project level include

  • Pharmaceutical Care Research Group , University of Basel
  • Swiss Federal Office of Public Health (BAG)
  • Helsana Group
  • Zürich University of Applied Sciences Winterthur, Winterthur Institute of Health Economics
  • University Hospital Jena, Germany
  • German Breast Group, Neu-Isenburg, Germany
  • St. Georges Hospital, London, UK
  • Department of  General Medical Oncology, University Hospitals Leuven, Leuven, Belgium
  • Swiss and international pharmaceutical and devices companies
  • Academic and non-academic healthcare providers